The introduction of SLNB has reduced the incidence of lymphedema in patients with node negative axillae but in patients with locally advanced breast cancer patients, ALND is still the standard of care. ARM has shown potential to identify the arm lymph nodes and lymphatics but is it really feasible in patients with LABC?